Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
A cryptic tubulin-binding domain links MEKK1 to curved tubulin protomersPavel Filipčík, Sharissa L Latham, Antonia L Cadell, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 20, 2021
In Vitro 3D Models of Tunable StiffnessElysse C Filipe, Amelia L Parker, Antonia L Cadell, et al.
Science Signaling|March 12, 2020
Structure-based mechanism of preferential complex formation by apoptosis signal-regulating kinasesSarah J Trevelyan, Jodi L Brewster, Abigail E Burgess, et al.
Science Advances|November 28, 2025
Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastomaJeremy Z R Han, Monica Phimmachanh, Jordan F Hastings, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 18, 2025
JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancerSarah Alexandrou, Christine S Lee, Kristine J Fernandez, et al.
Breast Cancer Research : BCR|March 23, 2019
Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancerSean P Kennedy, Jeremy Z R Han, Neil Portman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2025
PSKH1 kinase activity is differentially modulated via allosteric binding of Ca2+ sensor proteinsChristopher R Horne, Toby A Dite, Samuel N Young, et al.
Science Advances|March 3, 2023
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastomaJordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2024
Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid MetabolismElysse C Filipe, Sipiththa Velayuthar, Ashleigh Philp, et al.
Science Advances|July 3, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy responseBrooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.
Pageof 1